Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8258163
Small-molecule agonists for type-2 orexin receptor
granted -
US 8258148
Spiroindoline modulators of muscarinic receptors
granted -
US 8258142
Substituted 8-[6-amino-3-pyridyl]xanthines
granted -
US 8258122
3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
granted -
US 8258116
Combination therapy for the treatment of HCV infection
granted -
US 8257918
Intelligent nanomedicine integrating diagnosis and therapy
granted -
US 8258106
Immunostimulatory nucleic acid molecules
granted -
EP 2491925
Antitumorigene Kombinaton, die Cabazitaxel und Cisplatin umfasst
granted -
US 8252574
Pseudoinfectious flavivirus and uses thereof
granted -
US 8252538
MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
granted -
US 8252267
DKKL-1 splice product modulators for cancer diagnosis and therapy
granted -
US 8252291
Bacteriocins and novel bacterial strains
granted -
US 8251941
Selective cytopheresis devices and related methods thereof
granted -
US 8252280
MAPC generation of muscle
granted -
US 8252275
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
granted -
US 8252787
Protein kinase inhibitors
granted -
US 8252845
Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform
granted -
US 8252839
Compounds and methods for delivery of prostacyclin analogs
granted -
US 8252814
Agents and crystals for improving excretory potency of urinary bladder
granted -
US 8252807
Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products
granted -
US 8252841
Methods of inhibiting bacterial virulence and compounds relating thereto
granted -
US 8252756
Nucleic acid functionalized nanoparticles for therapeutic applications
granted -
US 8252767
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
granted -
US 8252764
Compositions and methods of use of targeting peptides against placenta and adipose tissues
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.